243 related articles for article (PubMed ID: 21303548)
1. Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.
El-Khatib Z; Ekstrom AM; Coovadia A; Abrams EJ; Petzold M; Katzenstein D; Morris L; Kuhn L
BMC Public Health; 2011 Feb; 11():88. PubMed ID: 21303548
[TBL] [Abstract][Full Text] [Related]
2. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.
Coovadia A; Hunt G; Abrams EJ; Sherman G; Meyers T; Barry G; Malan E; Marais B; Stehlau R; Ledwaba J; Hammer SM; Morris L; Kuhn L
Clin Infect Dis; 2009 Feb; 48(4):462-72. PubMed ID: 19133804
[TBL] [Abstract][Full Text] [Related]
3. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
[TBL] [Abstract][Full Text] [Related]
4. Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.
Milne RS; Silverman RA; Beck IA; Mckernan-Mullin J; Deng W; Sibley TR; Dross S; Kiarie JN; Sakr SR; Coombs RW; Chung MH; Frenkel LM
AIDS; 2019 May; 33(6):941-951. PubMed ID: 30946148
[TBL] [Abstract][Full Text] [Related]
5. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.
Kuhn L; Semrau K; Ramachandran S; Sinkala M; Scott N; Kasonde P; Mwiya M; Kankasa C; Decker D; Thea DM; Aldrovandi GM
J Acquir Immune Defic Syndr; 2009 Sep; 52(1):132-6. PubMed ID: 19506483
[TBL] [Abstract][Full Text] [Related]
6. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa.
El-Khatib Z; Katzenstein D; Marrone G; Laher F; Mohapi L; Petzold M; Morris L; Ekström AM
PLoS One; 2011 Mar; 6(3):e17518. PubMed ID: 21408071
[TBL] [Abstract][Full Text] [Related]
7. Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
Musoke P; Szubert AJ; Musiime V; Nathoo K; Nahirya-Ntege P; Mutasa K; Williams DE; Prendergast AJ; Spyer M; Walker AS; Gibb DM;
AIDS; 2015 Aug; 29(13):1623-1632. PubMed ID: 26193705
[TBL] [Abstract][Full Text] [Related]
8. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.
El-Khatib Z; Ekstrom AM; Ledwaba J; Mohapi L; Laher F; Karstaedt A; Charalambous S; Petzold M; Katzenstein D; Morris L
AIDS; 2010 Jul; 24(11):1679-87. PubMed ID: 20453629
[TBL] [Abstract][Full Text] [Related]
9. Outcomes after virologic failure of first-line ART in South Africa.
Murphy RA; Sunpath H; Lu Z; Chelin N; Losina E; Gordon M; Ross D; Ewusi AD; Matthews LT; Kuritzkes DR; Marconi VC;
AIDS; 2010 Apr; 24(7):1007-12. PubMed ID: 20397305
[TBL] [Abstract][Full Text] [Related]
10. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
[TBL] [Abstract][Full Text] [Related]
11. Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia.
Li JZ; Gallien S; Ribaudo H; Heisey A; Bangsberg DR; Kuritzkes DR
AIDS; 2014 Jan; 28(2):181-186. PubMed ID: 24361679
[TBL] [Abstract][Full Text] [Related]
12. Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.
Kekitiinwa A; Szubert AJ; Spyer M; Katuramu R; Musiime V; Mhute T; Bakeera-Kitaka S; Senfuma O; Walker AS; Gibb DM;
Pediatr Infect Dis J; 2017 Jun; 36(6):588-594. PubMed ID: 28505015
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.
Fielding KL; Charalambous S; Stenson AL; Pemba LF; Martin DJ; Wood R; Churchyard GJ; Grant AD
BMC Infect Dis; 2008 Jul; 8():93. PubMed ID: 18631397
[TBL] [Abstract][Full Text] [Related]
14. High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali.
Crowell CS; Maiga AI; Sylla M; Taiwo B; Kone N; Oron AP; Murphy RL; Marcelin AG; Traore B; Fofana DB; Peytavin G; Chadwick EG
Pediatr Infect Dis J; 2017 Nov; 36(11):e258-e263. PubMed ID: 28198788
[TBL] [Abstract][Full Text] [Related]
15. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
[TBL] [Abstract][Full Text] [Related]
17. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
[TBL] [Abstract][Full Text] [Related]
18. Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.
Chohan BH; Tapia K; Benki-Nugent S; Khasimwa B; Ngayo M; Maleche-Obimbo E; Wamalwa D; Overbaugh J; John-Stewart G
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):783-91. PubMed ID: 25819584
[TBL] [Abstract][Full Text] [Related]
19. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
[TBL] [Abstract][Full Text] [Related]
20. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
